ACLX — ARCELLX INC

Ownership history in GILEAD SCIENCES, INC.  ·  5 quarters on record

This page tracks every 13F SEC filing in which GILEAD SCIENCES, INC. reported a position in ARCELLX INC (ACLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
37.32% (2025 Q1)
Avg. % of fund
31.71%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 6,720,803 — 0% 22.64% $438.2M $65.20
2025 Q3 UNCHANGED 6,720,803 — 0% 30.80% $551.8M $82.10
2025 Q2 UNCHANGED 6,720,803 — 0% 34.57% $442.56B $65.85
2025 Q1 UNCHANGED 6,720,803 — 0% 37.32% $440.88B $65.60
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ACLX price (monthly, adj. close)

Other funds also holding ACLX

As of 2025 Q4 — sorted by position size

SR ONE CAPITAL MANAGEMENT, LP 3Y 21.66% NEA Management Company, LLC 3Y 7Y 10.12% Paradigm Biocapital Advisors LP 3Y 9.53% Vestal Point Capital, LP 6.48% STEMPOINT CAPITAL LP 3.72% Affinity Asset Advisors, LLC 3Y 1.95% Catalio Capital Management, LP 1.8% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.7% HighVista Strategies LLC 3Y 7Y 1.26% Atle Fund Management AB 3Y 7Y 0.87%
← Back to GILEAD SCIENCES, INC. Holdings